Business Context and Reporting Period
Company: Molina Healthcare, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 16, 2016
Event: Entry into Material Definitive Agreements regarding executive compensation.
Key Financial Metrics
This filing does not report operational financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive employment terms.
Material Changes
The company entered into second amended and restated employment agreements with CEO Dr. J. Mario Molina and CFO John C. Molina. Key changes include:
- Excise Tax Treatment: Removed Section 280G gross-up provisions. Executives now face an automatic reduction in change-in-control payments if the gross-up would result in a higher after-tax payment than paying the excise tax.
- Clawback Policy: All amounts payable are now subject to the company's clawback policy.
- Severance Structure (Termination without cause/Good Reason):
- Base severance increased to 400% of annual base salary.
- Termination amounts increased to 150% of base salary for Dr. Molina and 125% for John Molina.
- Continuing health and welfare benefits remain at $65,000 (18 months).
- Change in Control Severance:
- Payment set at 400% of annual base salary plus prorated termination bonus.
- Continuing health and welfare benefits increased to $135,000 (36 months).
- Includes accelerated vesting of all unvested equity.
- Contract Duration: Agreements no longer terminate automatically at age 65; they now renew annually unless terminated.
- Salary Adjustments (Fiscal 2016):
- Dr. J. Mario Molina: Increased to $1,170,000.
- John C. Molina: Remains at $878,000.
Guidance, Outlook, and Risks
Management Commentary: The filing details the restructuring of executive compensation to align with tax efficiency and company policy regarding clawbacks.
Contingencies: Severance payments are contingent upon the executive signing a release agreement waiving claims against the company.
Risks: The filing does not disclose new operational risks, though the increased severance obligations represent a potential future liability in the event of executive departure or a change in control.
Investor Verification Checklist
- Verify the exact text of the clawback policy referenced in the new agreements.
- Confirm the total potential liability exposure for change-in-control scenarios based on the new 400% salary multiplier and 36-month health benefits.
- Review the impact of the salary increase for the CEO on the company's total executive compensation expense for fiscal year 2016.
- Check subsequent filings for any further amendments to the equity vesting schedules mentioned.